Grolleman JE et al. (2021) Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype. Cancer Cell 35(2):256-266.e5 doi:10.1016/j.ccell.2018.12.011 <button class="btn" onclick="window.location.href='https://doi.org/10.1016/j.ccell.2018.12.011';">GO</button>
Li N et al. (2021) Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects. npj Breast Cancer 7, 52 doi:10.1038/s41523-021-00255-3 <button class="btn" onclick="window.location.href='https://doi.org/10.1038/s41523-021-00255-3';">GO</button>
Nguyen-Dumont T et al. (2021) Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer. Cancers (Basel) 13(7):1495 doi:10.3390/cancers13071495 <button class="btn" onclick="window.location.href='https://doi.org/10.3390/cancers13071495';">GO</button>
Nguyen-Dumont T et al. (2021) Population-Based Estimates of the Age-Specific Cumulative Risk of Breast Cancer for Pathogenic Variants in CHEK2: Findings from the Australian Breast Cancer Family Registry. Cancers (Basel) 13(6):1378 doi:10.3390/cancers13061378 <button class="btn" onclick="window.location.href='https://doi.org/10.3390/cancers13061378';">GO</button>
Southey MC et al. (2021) Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing. npj Breast Cancer 7, 153 doi:10.1038/s41523-021-00360-3 <button class="btn" onclick="window.location.href='https://doi.org/10.1038/s41523-021-00360-3';">GO</button>
Figlioli G et al. (2020) The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases. Cancers 12, 292 doi:10.3390/cancers12020292 <button class="btn" onclick="window.location.href='https://doi.org/10.3390/cancers12020292';">GO</button>
Yang X et al. (2020) Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. Journal of Clinical Oncology 38(7):674-685 doi:10.1200/JCO.19.01907 <button class="btn" onclick="window.location.href='https://doi.org/10.1200/JCO.19.01907';">GO</button>
Elsayed FA et al. (2020) Monoallelic NTHL1 Loss of Function Variants and Risk of Polyposis and Colorectal Cancer. Gastroenterology 159(6):2241-2243.e6 doi:10.1053/j.gastro.2020.08.042 <button class="btn" onclick="window.location.href='https://doi.org/10.1053/j.gastro.2020.08.042';">GO</button>
Myszka A et al. (2020) Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer? Genetics Research 102:e6 doi:10.1017/S0016672320000075 https://doi.org/10.1017/S0016672320000075 <button class="btn" onclick="window.location.href='https://doi.org/10.1017/S0016672320000075';">GO</button>
Nguyen-Dumont T et al. (2020) Mismatch repair gene pathogenic germline variants in a population-based cohort of breast cancer (2020) Familial Cancer 19(3):197-202 doi:10.1007/s10689-020-00164-7 <button class="btn" onclick="window.location.href='https://link.springer.com/article/10.1007/s10689-020-00164-7';">GO</button>
Nguyen-Dumont T et al. (2020) Rare germline genetic variants and risk of aggressive prostate cancer. International Journal of Cancer 147(8):2142-2149 doi:10.1002/ijc.33024 <button class="btn" onclick="window.location.href='https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.33024';">GO</button>
Hammet F et al. (2019) Hi-Plex2: a simple and robust approach to targeted sequencing-based genetic screening. BioTechniques 67(3):118-122 doi:10.2144/btn-2019-0026 <button class="btn" onclick="window.location.href='https://www.future-science.com/doi/10.2144/btn-2019-0026';">GO</button>
Pope BJ et al. (2018) Hi-Plex for Simple, Accurate, and Cost-Effective Amplicon-based Targeted DNA Sequencing. Methods in Molecular Biology 1712:53-70 doi:10.1007/978-1-4939-7514-3_5 <button class="btn" onclick="window.location.href='https://doi.org/10.1007/978-1-4939-7514-3_5';">GO</button>
Nguyen-Dumont T et al. (2018) FANCM and RECQL genetic variants and breast cancer susceptibility: Relevance to South Poland and West Ukraine. BMC Medical Genetics 19(1):12 doi:10.1186/s12881-018-0524-x <button class="btn" onclick="window.location.href='https://doi.org/10.1186/s12881-018-0524-x';">GO</button>
Nguyen-Dumont T et al. (2018) Is RNASEL: P.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations? BMC Cancer 18(1):165 doi:10.1186/s12885-018-4028-z <button class="btn" onclick="window.location.href='https://doi.org/10.1186/s12885-018-4028-z';">GO</button>
Myszka A et al. (2018) Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine. Familial Cancer 17(3):345-349 https:doi:10.1007/s10689-017-0050-6 <button class="btn" onclick="window.location.href='https://doi.org/10.1007/s10689-017-0050-6';">GO</button>
Mahmoodi M et al. (2017) Mutation screening of ACKR3 and COPS8 in kidney cancer cases from the CONFIRM study. Familial Cancer 16(3):411-416 doi:10.1007/s10689-016-9961-x <button class="btn" onclick="window.location.href='https://link.springer.com/article/10.1007/s10689-016-9961-x';">GO</button>
Park DJ et al. (2016). UNDR ROVER â€“ A fast and accurate variant caller for targeted DNA sequencing. BMC Bioinformatics 17:165 doi:10.1186/s12859-016-1014-9 <button class="btn" onclick="window.location.href='https://doi.org/10.1186/s12859-016-1014-9';">GO</button>
Hasmad HN et al. (2016). Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients. Gynecologic Oncology pii:S0090-8258:30173-30176 doi:10.1016/j.ygyno.2015.11.001 <button class="btn" onclick="window.location.href='https://doi.org/10.1016/j.ygyno.2015.11.001';">GO</button>
Nguyen-Dumont T et al. (2015). Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry. Breast Cancer Research and Treatment 149:547-554 doi:10.1007/s10549-014-3260-8 <button class="btn" onclick="window.location.href='https://doi.org/10.1007/s10549-014-3260-8';">GO</button>
Nguyen-Dumont T et al. (2015). Hi-Plex targeted sequencing is effective using DNA derived from archival dried blood spots. Analytical Biochemistry 470:48-51 doi:10.1016/j.ab.2014.10.010 <button class="btn" onclick="window.location.href='https://doi.org/10.1016/j.ab.2014.10.010';">GO</button>
Nguyen-Dumont T et al. (2015). Use of abridged adapter primers increases the target scope of Hi-Plex. BioTechniques 58:33-36 doi:10.2144/000114247 <button class="btn" onclick="window.location.href='https://www.future-science.com/doi/full/10.2144/000114247';">GO</button>
Pope BJ et al. (2014). ROVER variant caller: read-pair overlap considerate variant-calling software applied to PCR-based massively parallel sequencing datasets. Source Code for Biology and Medicine 9:3 doi:10.1186/1751-0473-9-3 <button class="btn" onclick="window.location.href='https://doi.org/10.1186/1751-0473-9-3';">GO</button>
Nguyen-Dumont T et al. (2013). Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2. BMC Medical Genomics 6:48 doi:10.1186/1755-8794-6-48 <button class="btn" onclick="window.location.href='https://bmcmedgenomics.biomedcentral.com/articles/10.1186/1755-8794-6-48';">GO</button>
Nguyen-Dumont T et al. (2013). Cross-platform compatibility of Hi-Plex, a streamlined approach for targeted massively parallel sequencing. Analytical Biochemistry 442:127-129 doi:10.1016/j.ab.2013.07.046 <button class="btn" onclick="window.location.href='https://doi.org/10.1016/j.ab.2013.07.046';">GO</button>
Nguyen-Dumont T et al. (2013). A high-plex PCR approach for massively parallel sequencing. BioTechniques 55:69-74 doi:10.2144/000114052 <button class="btn" onclick="window.location.href='https://www.future-science.com/doi/10.2144/000114052';">GO</button>
